Assessment of inhalation technique and predictors of incorrect performance among patients of chronic obstructive pulmonary disease and asthma

Tulika Jha; Ashok Kumar Sahai; Malay Sarkar; Purshottam Kumar Kaundal; Praveen Bhardwaj; Indrajeet Sharma

doi:10.18203/2319-2003.ijbcp20162479

Authors

Tulika Jha Department of Pharmacology,Indira Gandhi Medical College, Shimla-1, Himachal Pradesh, India
Ashok Kumar Sahai Department of Pharmacology,Indira Gandhi Medical College, Shimla-1, Himachal Pradesh, India
Malay Sarkar Department of Pulmonary Medicine,Indira Gandhi Medical College, Shimla-1, Himachal Pradesh, India
Purshottam Kumar Kaundal Department of Pharmacology,Indira Gandhi Medical College, Shimla-1, Himachal Pradesh, India
Praveen Bhardwaj Department of Paediatrics, Indira Gandhi Medical College, Shimla-1, Himachal Pradesh, India
Indrajeet Sharma Department of Pharmacology, AIMS, Rajsamand, India

DOI:

https://doi.org/10.18203/2319-2003.ijbcp20162479

Keywords:

Asthma, COPD, DPI, ERS/ISAM, pMDI Spacer

Abstract

Background: Poor inhalation technique is responsible for decreasing the efficacy of topical drug therapy in asthma and chronic obstructive pulmonary disease (COPD). Certain steps of the inhalation technique are erred most often and if ascertained, can be rectified leading to an overall improvement in the technique. The predictors for poor use can also be marked.

Methods: Inhaler technique for pressurised metered dose inhalers (pMDI), pressurised metered dose inhaler with spacer and dry powder inhaler (DPI) was assessed in one hundred and five patients who fulfilled the inclusion and exclusion criteria and were enrolled in this study. Inhaler technique was assessed using an ERAS/ISAM Task force report based scores and the lung function using pulmonary function test (PFT).The technique was re-assessed and scored after a period of three months along with the assessment of the lung function by PFT.

Results: The mean of ERS/ISAM task force report based score for evaluation of the techniques of inhalation increased from 5.79±2.58 to 8.23±2.41 (p<0.0001) after intervention. The most commonly committed error in the inhalation technique was in step number eight, ten and four by patients using pMDI, pMDI with spacer and DPI, respectively. The faulty technique being the dependent variable/outcome could be explained 16% by the type of inhaler used (r2 = 0.1607) and this is statistically significant (p<0.0001), thus the type of inhaler used was a predictor of poor use.

Conclusions: Inhaler techniques improved with systematic training and there was a trend towards improvement in lung function, hence the clinical condition.

Metrics

Metrics Loading ...

References

Newman SP. Inhaler treatment options in COPD. Eur Respir Rev. 2005;14:102-8.

Fabbri LM, Hurd SS. Global Strategy for the diagnosis, management and prevention of COPD: 2003 update. Eur Respir J. 2003;22:1-2.

Celli BR, MacNee W. Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper. Eur Respir J. 2004;23:932-46.

Global strategy for asthma management and prevention. NHLBI/WHO workshop report number 95–3659. Bethesda, National Institute of Health, 2002. Available at http://www.ginasthma.org.

Dolovich MB, Ahrens RC, Hess DR, Anderson P, Dhand R, Rau JL, et al. Device selection and outcomes of aerosol therapy: evidence-based guidelines: American College of Chest Physicians/American College of Asthma, Allergy, and Immunology. Chest. 2005;127:335-71.

Newman SP, Pavia D, Clarke SW. How should a pressurized beta-adrenergic bronchodilator be inhaled? Eur J Respir Dis. 1981;62:3-21.

Hindle M, Newton DA, Chrystyn H. Investigations of an optimal inhaler technique with the use of urinary salbutamol excretion as a measure of relative bioavailability to the lung. Thorax. 1993; 48:607-10.

Crompton GK. Problems patients have using pressurized aerosol inhalers. Eur J Respir Dis Suppl. 1982;119:101-04.

Newman SP. Spacer devices for metered dose inhalers. Clin Pharmacokinet. 2004;43:349-60.

Smith IJ, Parry-Billings M. The inhalers of the future? A review of dry powder devices on the market today. Pulm PharmacoTher. 2003;16(2):79-95.

Serra-Batlles J, Plaza V, Badiola C, Morejon E. Patient perception and acceptability of multidose dry powder inhalers: a randomized crossover comparison of diskus/accuhaler with turbuhaler. J Aerosol Med. 2002;15(1):59-64.

Epstein S, Maidenberg A, Hallett D, Khan K, Chapman KR. Patient handling of a dry-powder inhaler in clinical practice. Chest. 2001;120(5):1480-84.

Fink JB, Rubin BK. Problems with inhaler use: a call for improved clinician and patient education. Respir Care. 2005;50:1360-75.

Lindgren S, Bake B, Larsson S. Clinical consequences of inadequate inhalation technique in asthma therapy. Eur J Respir Dis. 1987;70:93-8.

Wright J, Brocklebank D, Ram F. Inhaler devices for the treatment of asthma and chronic obstructive airways disease (COPD). Qual Saf Health Care. 2002;11(4):376-82.

Laube BL, Janssens HM, De Jongh FH, Devadason SG, Dhand R, Diot P, et al. European respiratory society; International society for aerosols in medicine: what the pulmonary specialist should know about the new inhalation therapies. Eur Respir J. 2011;37:1308-31.

De Blaquiere P, Christensen DB, Carter WB, Martin TR. Use and misuse of metered-dose inhalers by patients with chronic lung disease. A controlled, randomized trial of two instruction methods. Am Rev Respir Dis. 1989;140:10-6.

Shrestha M, Parupia H, Andrews B, Kim SW, Martin MS, Park DI, et al. Metered-dose inhaler technique of patients in an urban ED: prevalence of incorrect technique and attempt at education. Am J Emerg Med. 1996;14:380-4.

Fink JB. Inhalers in asthma management: is demonstration the key to compliance? (editorial) Respir Care. 2005;50(5):598-600.

Turner MO, Patel A, Ginsburg S. Bronchodilator delivery in acute airflow obstruction. Arch Intern Med. 1997;157:1736-44.

Fink JB, Rubin BK. Problems with inhaler use: a call for improved clinician and patient education. Respir Care. 2005;50:1360-75.

Broeders ME, Sanchis J, Levy ML, Crompton GK, Dekhuijzen PN: The ADMIT series-issues in inhalation therapy. Improving technique and clinical effectiveness. Prim Care Respir J. 2009;18:76-82.

Melani AS. Inhalatory therapy training: a priority challenge for the physician. Acta Biomed. 2007;78:233-45.

Guidry GG, Brown WD, Stogner SW, George RB. Incorrect use of metered dose inhalers by medical personnel. Chest. 1992;101:31-3.

Hanania NA, Wittman R, Kesten S, Chapman KR. Medical personnel’s knowledge of and ability to use inhaling devices. Metered-dose inhalers, spacing chambers, and breath-actuated dry powder inhalers. Chest. 1994;105:111-6.

Brocklebank D, Ram F, Wright J, Barry P, Cates C, Davies L, et al. Comparison of the effectiveness of inhaler devices in asthma and chronic obstructive airways disease: a systematic review of the literature. Health Technol Assess. 2001;5(26):1-149.

Newman SP, More´n F, Pavia D, Little F, Clarke SW. Deposition of pressurized suspension aerosols inhaled through extension devices. Am Rev Respir Dis. 1981;124(3):317-20.

Siafakas NM, Vermeire P, Pride NB, Paoletti P, Gibson J, Howard P, et al. Optimal assessment and management of chronic obstructive pulmonary disease (COPD). The European Respiratory Society Task Force. Eur Respir J. 1995;8:1398-20.

Guidelines for the diagnosis and management of Asthma. NIH publication no. 97-4051. Bethesda, MD: NIH; 1997. Available at https://www.nhlbi.nih.gov/files/docs/guidelines/asthgdln_archive.pdf.

Diggory P, Bailey R, Vallon A. Effectiveness of inhaled bronchodilator delivery system for elderly patients. Age Ageing. 1991;20:379-82.

Van der Palen J, Klein J, Rovers M. Compliance with inhaled medication and self-treatment guidelines following a self-management programme in adult asthmatics. Eur Respir J. 1997;10:652-7.

Vincken W, van Noord JA, Greefhorst AP. Improved health outcomes in patients with COPD during 1 yr’s treatment with tiotropium. Eur Resp J. 2002;19:209-16.